The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX).
The investment seeks long-term capital appreciation.
Under normal conditions, the fund will invest at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in equity and equity-related securities of health care-related companies. The Advisor considers health care-related companies to be those companies that operate in, or are related to, the major subsectors of the health care sector, including pharmaceuticals, biotechnology, health care technology, life sciences tools and services, health care equipment and supplies, and health care providers and services.
The average market capitalization across the Lord Abbett Health Care R5 MF is 120.96B. The market cap for tickers in the group ranges from 7.55B to 561.54B. LLY holds the highest valuation in this group at 561.54B. The lowest valued company is NOV at 7.55B.
The average weekly volume growth across all stocks in the Lord Abbett Health Care R5 MF was 35%. For the same stocks of the MF, the average monthly volume growth was 20% and the average quarterly volume growth was 22%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 57
P/E Growth Rating: 56
Price Growth Rating: 47
SMR Rating: 61
Profit Risk Rating: 38
Seasonality Score: -3 (-100 ... +100)